BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5549411)

  • 1. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY; Colburn RW; Kopin IJ
    Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 3. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L
    Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 6. Central decarboxylation and uptake of L-DOPA.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):11-26. PubMed ID: 4260798
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin synthesis with rat brain synaptosomes. Effects of L-dopa, L-3-methoxytyrosine and catecholamines.
    Karobath M; Diaz JL; Huttunen M
    Biochem Pharmacol; 1972 May; 21(9):1245-51. PubMed ID: 5038670
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 9. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 11. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U
    Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
    [No Abstract]   [Full Text] [Related]  

  • 12. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 14. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 15. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation.
    Pletscher A; Bartholini G
    Clin Pharmacol Ther; 1971; 12(2):344-52. PubMed ID: 5577483
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 18. L-Dopa-induced release of cerebral monoamines.
    Ng KY; Chase TN; Colburn RW; Kopin IJ
    Science; 1970 Oct; 170(3953):76-7. PubMed ID: 5452893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of various agents on the pressor response to dopa in the anesthetized dog.
    Pruss TP; McGill JS
    Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043
    [No Abstract]   [Full Text] [Related]  

  • 20. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.